Don't Ignore This Chart!

Bio Image
About this blog: Don't Ignore This Chart!The Don't Ignore This Chart blog contains daily articles with intriguing or unusual charts selected by one of our Senior Technical Analysts, along with a short explanation of what exactly caught their attention and why they believe the chart is worth noting. Learn More

Latest Posts

Don't Ignore This Chart!

Blog Article Title Image

Tesla Stock's Shocking Comeback: What You Need to Know Before July 23

by Karl Montevirgen

Tesla (TSLA) shares staged a dramatic recovery ahead of the company's upcoming earnings report scheduled for July 23. Despite a slip in its deliveries compared to a year ago, the number of deliveries beat Wall Street's expectations...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Could AMZN's Stock Hit $3 Trillion Valuation? What You Need To Know

by Karl Montevirgen

Amazon (AMZN) has broken out into all-time high territory, closing at $200.02 (above last week's all-time high mark of $199.84). AMZN stock is firing on all cylinders and ready to take on all AI titans as it enters the space from the e-commerce angle...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Can Nvidia's Stock Skyrocket Again? Key Levels to Watch Now!

by Karl Montevirgen

Waiting for a perfect setup—technically or fundamentally—can sometimes be a perfect way to miss an opportunity. The disruptor is market sentiment, as it jumps the gun on an opportunity hoping to be validated well after pulling the trigger...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Why Investors are Betting Big on Berkshire Hathaway Class B Shares Right Now

by Karl Montevirgen

Berkshire Hathaway needs no introduction. The name is synonymous with two iconic investors—Warren Buffett (the Oracle of Omaha) and the late Charlie Munger...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Gilead's Game-Changer: What You Need to Know About the Stock

by Karl Montevirgen

Gilead Sciences' (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated in the trial, and none of them contracted HIV, signaling a potential game-changer for HIV prevention...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Seasonality Suggests a Massive Energy Market Shift This Summer—Are You Ready?

by Karl Montevirgen

We're heading deeper into the summer months, which usually means higher demand for energy products, namely crude oil and gas. While demand tends to be seasonal, the entire crude complex is also sensitive to changes in macroeconomic and geopolitical environments...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Bitcoin, Politics, and Profits: What You Need to Know About CleanSpark and Riot Platforms

by Karl Montevirgen

While money (the thing itself) knows no politics, its production and distribution are often soaked in it. While Bitcoin isn't a functioning currency, many consider it an antidote to "bad money." Perhaps that accounts for its 3.85% spike earlier in the week...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Retail Stocks Caught in Limbo: Will RTH Break Free and Soar?

by Karl Montevirgen

VanEck Vectors Retail ETF (RTH) is a peculiar beast. It holds 26 retail stocks, 70% in the Consumer Discretionary sector and 30% in Consumer Staples...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Will Spotify Smash Its All-Time High of $387?

by Karl Montevirgen

Music streamer Spotify Technology (SPOT) isn't a cheap stock. But it might not be considered overvalued either, despite its earnings having been rather "spotty" (pardon the pun) and dipping into negative territory before last October...Read More 

Don't Ignore This Chart!

Blog Article Title Image

Is Aflac Set to Surpass Analysts' Targets? Find Out Now!

by Karl Montevirgen

Boring and captivating rarely coexist, except for contrarians who can uncover the subtle allure in what the mainstream finds mundane. Yet discovering the next "hot" stock often demands looking at assets the popular crowd undervalues and ignores...Read More